Clinical Trials Browser

Phase 2/3 × Interventional × Liver Neoplasms × Clear all

NCT05153785 2026-01-15

Perioperative Intravenous Lidocaine in Liver Surgery

Phase 2/3 Completed

Gastrointestinal

Liver Neoplasms, Pain, Postoperative

NCT06851663 2025-12-08

Trop2-targeted immunoPET Imaging of Solid Tumors

Phase 2/3 Recruiting

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT05033522 2025-10-23

ALIVE

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06478108 2024-06-27

Interventional Software for Multi-immunotherapy of Solid Tumors

Phase 2/3 Recruiting

GastrointestinalThoracic

Liver Neoplasms, Lung Neoplasms

NCT05322187 2022-04-11

sPLENTY-pc

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

NCT01164202 2022-03-18

SATURNE

Phase 2/3 Completed

78 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03592706 2020-04-16

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04206254 2019-12-20

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms

NCT01932385 2018-02-14

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01901692 2017-09-18

START

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02829359 2017-06-12

HBV-DNA(-)

Phase 2/3 Completed

Gastrointestinal

Liver Neoplasms

NCT00304135 2016-05-30

Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

Phase 2/3 Completed

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms

NCT00827554 2016-04-01

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT00332280 2013-03-20

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Phase 2/3 Terminated

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT01655641 2012-10-16

TMGS

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT00151671 2012-02-27

IMPACT

Phase 2/3 Terminated

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT01436721 2011-09-20

Use of an Oxidized Regenerated Cellulose After Hepatic Surgery

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms

NCT00728078 2009-02-09

LDT-RFA

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00034333 2005-06-24

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

Phase 2/3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00057382 2005-06-24

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Phase 2/3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms